NEW YORK (GenomeWeb News) – Agilent Technologies priced its public offering of senior notes at an aggregate principal amount of $400 million after the close of the market on Monday.

The notes will mature in October 2022 and bear interest at an annual rate of 3.20 percent.

The Santa Clara, Calif.-based company announced the offering earlier on Monday but did not price it. Following the announcement, ratings agencies Moody's and Fitch issued ratings on the notes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: mouse genome functional analysis, more sensitive chromatin immunoprecipitation, and more.

The Center for Data Innovation and HealthITNow argue for re-building of genomic research infrastructure.

A Senate committee has unanimously approved a bill to require articles resulting from federally funded projects to be made publicly available, according to ScienceInsider.

The US is heading toward another budget showdown, Nature News says.